BRIEF-Theon Says Co. Plans To Acquire 9.8% Stake In Exosens-March 2024-www.financetom.com

BRIEF-Theon Says Co. Plans To Acquire 9.8% Stake In Exosens

News World Market Environment Technology Personal Finance Politics Retail Business Economy Cryptocurrency Forex Stocks Market Commodities

BRIEF-Theon Says Co. Plans To Acquire 9.8% Stake In Exosens

Oct 11, 2025 3:26 AM

Oct 11 (Reuters) - Theon International Plc:

* THEON PLANS TO ACQUIRE 9.8% STAKE IN EXOSENS

* THEON INTERNATIONAL PLC - TO BUY 9.8% STAKE IN EXOSENS FOR

€268.7 MILLION

Source text:

Further company coverage:

Previous page： Rigetti Computing Prices Direct Offering of 50 Million Shares at $2 per Share Next page： VinFast Auto's Q3 Loss Narrows, Revenue Rises

Comments

Welcome to financetom comments! Please keep conversations courteous and on-topic. To fosterproductive and respectful conversations, you may see comments from our Community Managers.

Show More Comments

Related Articles >

Rigetti Computing Prices Direct Offering of 50 Million Shares at $2 per Share

Nov 26, 2024

08:41 AM EST, 11/26/2024 (MT Newswires) -- Rigetti Computing ( RGTI ) said Tuesday it has entered into agreements with two institutional investors to sell 50 million shares of common stock at $2 per share for gross proceeds of about $100 million in a direct offering. Proceeds from the offering, expected to close Wednesday, would be used for working capital...

VinFast Auto's Q3 Loss Narrows, Revenue Rises

Nov 26, 2024

08:32 AM EST, 11/26/2024 (MT Newswires) -- VinFast Auto ( VFS ) reported a Q3 loss Tuesday of 5,656 Vietnamese dong ($0.22) per diluted share, narrower than a loss of 6,725 Vietnamese dong a year earlier. Three analysts polled by FactSet expected a loss of 6,948.13 Vietnamese dong. Revenue for the quarter that ended Sept. 30 was 12,326,537 million dong,...

Amgen Reveals Data From Closely Watched Monthly Obesity Drug, With Weight Loss Of Up To 20% At One Year And No Plateau

Nov 26, 2024

On Tuesday, Amgen Inc ( AMGN ) stock fell during the premarket session after the company released long-anticipated data from the Phase 2 study of MariTide (maridebart cafraglutide, formerly AMG 133) in obese patients. The company said that MariTide demonstrated up to ~20% average weight loss at one year (52 weeks) without a weight loss plateau, indicating the potential for further...

Toyo Executes $150 Million Solar Cell Supply Contract

Nov 26, 2024

08:32 AM EST, 11/26/2024 (MT Newswires) -- Toyo (TOYO) said Tuesday that a $150 million contract to supply high-efficiency solar cells for a solar module manufacturer has been executed. Under the terms of the deal, Toyo said it will deliver its solar cells to support its customer's solar module production in India and the US. Toyo said it will use...